Use access key #2 to skip to page content.

portefeuille (99.60)

Ellipsis

Recs

4

August 17, 2009 – Comments (13)

I have renamed my 11 players that were not named "portefeuille".

hdgf2 → portefeuille2
hdgf1 → portefeuille3
tirezsur → portefeuille4
mantil → portefeuille5
hansschmidt → portefeuille6
markethypothesis → portefeuille7
hedgefunda → portefeuille8
ahedgefund → portefeuille9
algo1 → portefeuille10
nonefficient → portefeuille11
20minutedelay → portefeuille12

 

 



enlarge

13 Comments – Post Your Own

#1) On August 17, 2009 at 1:00 PM, throwerw (29.48) wrote:

if you wanted to, you could give yourself 11 recs for every post you make

Report this comment
#2) On August 17, 2009 at 1:15 PM, portefeuille12 (28.83) wrote:

I noticed that the popularity (as displayed by the number of players that have chosen a particular one of those 11 as one of their "favourite" players) of those 11 players does not necessarily correlate with their "track record". portefeuille is my "main player" and the only one that at least sometimes tries to make some "useful" comments in the "caps" game blog section. Those other 11 are all rather "silent" so their popularity should correlate rather closely to their track record as to making good calls. It does not. So either it is correlated to the names or to their strategies but the variation in number of "groupies" is certainly to large to be explained by chance.

So let's see whether this renaming levels the playing field. I am glad I did not choose to start a 13th player since I guess the name portefeuille13 would have given him a hard time in the popularity race, hehe ...

This is the number of "groupies" of my players from portefeuille to portefeuille12 (at the last time I checked).

352 73 26 15 39 40 9 14 24 4 5 2.

portefeuille7 (the player formerly known as "markethypothesis") for example currently has ca. 9 "groupies". He is currently ranked ca. #67 in the "caps" game. 

 

Report this comment
#3) On August 17, 2009 at 1:17 PM, mikecart1 (99.04) wrote:

Man you got too much free time LOL. :D

Report this comment
#4) On August 17, 2009 at 1:22 PM, portefeuille12 (28.83) wrote:

if you wanted to, you could give yourself 11 recs for every post you make

I could even give myself 12 since the writer is allowed to recommend his own posts (I think). I guess that the lack of drama headlines and exclamation mark massacres proves that I am not that interested in recommendations.

79 posts, ca. 433 recommendations so far.

Report this comment
#5) On August 17, 2009 at 1:32 PM, portefeuille12 (28.83) wrote:

number1cramerfan currently has ca. 15 "groupies". He is #5 as to score points (I am #4, hehe) and #3 as to "outperform score" (I am #2, hehe).

His name choice is "unfortunate" I guess, but come on ... 15 groupies? 15?

What is really ridiculous is that he is absent from the "highest-rated members" list since it only shows the top1000 is he is currently ca. #2089. This accuracy is really getting more and more absurd ...

 

 

 

Report this comment
#6) On August 17, 2009 at 1:40 PM, portefeuille (99.60) wrote:

So kids, go check out all of my players (and number1cramerfan if you can't help it, hehe). It is all me, the same genius that is giving you this list of calls, hehe ... 

 

 

 

-----------------

#6) On August 15, 2009 at 4:03 AM, portefeuille (99.98) wrote:

relative change for the stocks that are the objects of "outperform" calls made here.

(dividends not included. this is the relative change for the period starting at the time the call was made and ending 08/14/09 4 p.m. ET. so this is performance, not outperformance measured against the benchmark. there may be errors in the list)

 

HGSI Human Genome Sciences, Inc. 3094.00
VVTV ValueVision Media, Inc. 1074.07
CENX Century Aluminum Company 940.54
SEH SPARTECH CP 787.92
NVAX Novavax, Inc. 641.54
FITB Fifth Third Bancorp 621.23
LVS LAS VEGAS SANDS CORP 569.35
GMK GRUMA SAB DE CV ADS 561.29
BGP BORDERS GRO INC 538.18
BLC BELO CORP 521.82
GTCB GTC Biotherapeutics Inc 512.12
IFNNY.PK INFINEON TECH ADS 484.81
BCS BARCLAYS PLC ADR 482.32
SOA SOLUTIA INC NEW 452.53
DNDN Dendreon Corporation 450.74
CROX Crocs, Inc. 440.17
PSM.DE PROSIEBEN SAT.1 VZ 401.61
MIC MACQUARIE INFSTC LLC 373.40
KFN KKR FINANCIAL CORP. 360.61
STEC STEC, Inc. 360.26
IMMU Immunomedics, Inc. 351.04
F FORD MOTOR CO 337.43
BAC BK OF AMERICA CP 332.59
UIS UNISYS CP 322.00
EBKDY.PK ERSTE GRO BK ADR 317.54
ING ING GROUP NV ADS 302.92
ACAS American Capital Strategies, Lt 292.00
SWCEY.PK SWISS REINSURANC ADR 288.84
AIB ALLIED IRISH PLC ADS 287.88
PMI P M I GROUP INC 278.79
YMI YM BIOSCIENCES INC 278.26
IP INTL PAPER 276.46
MAC MACERICH CO 260.68
UNCFF.PK UNICREDITO ITALIA AZ 254.84
AIXG Aixtron Aktiengesellschaft 246.40
DOW DOW CHEMICAL 244.17
DDR DEVELOPERS RLTY 242.98
CRAY Cray Inc 241.77
AFFX Affymetrix, Inc. 233.96
...
...
ZQK QUIKSILVER CP -10.24
NBIX Neurocrine Biosciences, Inc. -10.32
ANSV Anesiva, Inc. -10.36
NCS NCI BLDG SYS INC -10.45
GSIG GSI Group, Inc. -10.72
GENZ Genzyme Corporation -10.79
BIOC BioClinica, Inc. -11.12
APM.DE AD PEPPER MEDIA -11.76
CPD CARACO PHARMA LABS -12.69
SWV.DE SOLARWORLD -13.18
SGL.F SGL CARBON -14.24
RHIE RHI ENTERTAINMENT -14.69
FSLR First Solar, Inc. -15.21
MYGN Myriad Genetics, Inc. -17.68
QCE.DE Q-CELLS -18.82
GPC.DE GPC BIOTECH AG -18.87
ARYX ARYx Therapeutics, Inc. -22.25
SLTC Selectica, Inc. -23.18
WNR WESTERN REFINING INC -24.91
PEIX Pacific Ethanol, Inc. -25.21
PLUG Plug Power, Inc. -26.92
ABII Abraxis Bioscience Inc. -27.14
UNG US NAT GAS FD ETF -27.89
CGY.DE CONERGY -30.11
JAV JAVELIN PHARMACEUTIC -30.95
BBI BLOCKBUSTER INC -34.55
ANDS Anadys Pharmaceuticals, Inc. -37.03
OMEX Odyssey Marine Exploration, Inc -46.99
RPRX Repros Therapeutics Inc. -56.77
SQNM Sequenom, Inc. -65.16
ARO.DE ARCANDOR -81.76
EPIX.OB EPIX PHARMACEUTICALS -97.27

----------------- 

(from here)

 

Report this comment
#7) On August 17, 2009 at 1:42 PM, portefeuille (99.60) wrote:

************************************************************************************

a guide to my blog posts can be found in the comment section to this post

(should be or should be close to the last comment)                                                                

************************************************************************************

Report this comment
#8) On August 17, 2009 at 3:27 PM, portefeuille (99.60) wrote:












Report this comment
#9) On August 17, 2009 at 3:38 PM, portefeuille (99.60) wrote:

----------------- 

Ariad Pharmaceuticals shares rise on upbeat note

Ariad Pharmaceuticals initiated at 'Outperform' on prospects for cancer drug, shares rise

On Monday August 17, 2009, 12:08 pm EDT

NEW YORK (AP) -- Shares of Ariad Pharmaceuticals Inc. rose on Monday even as the broader markets fell after an analyst said the company's lead drug candidate has good prospects.

Bret Holley of Oppenheimer initiated the stock with an "Outperform" rating and a $4 price target, implying he expects shares to more than double from Friday's close of $1.95.

Cambridge, Mass.-based Ariad, which focuses on cancer treatments, has no products on the market. Its lead candidate, which Aria is developing with partner Merck & Co., is indicated for sarcoma. The product is currently in late-stage testing with study data due in the first half of next year.

Holley said that based on strong data in midstage tests, he expects a "good probability" of positive data and eventually marketing approval from the Food and Drug Administration for the drug, called ridaforolimus.

The analyst estimated the drug could eventually bring in annual sales of about $350 million worldwide, and possibly better, based on its testing in other cancers.

"Aria's ridaforolimus partnership with Merck increases our confidence in the drug's ultimate success," Holley noted. "Ridaforolimus is in phase II testing in multiple cancer settings, demonstrating Merck's commitment to the drug. Despite near-term cost concerns, we view the 50/50 partnership positively for Ariad, based on meaningful near-term milestone payments and substantial longer-term revenue upside."

In midday trading, Ariad Pharmaceuticals rose 7 cents, or 3.6 percent, to $2.02. The stock has more than doubled in the year to date and traded at 72 cents last December.

----------------- 

 

Report this comment
#10) On August 17, 2009 at 3:41 PM, portefeuille (99.60) wrote:

Ariad Pharmaceuticals: Significant Catalysts Approaching

 

 

----------------- 

#201) On March 14, 2009 at 12:24 AM, portefeuille (99.98) wrote: ARIA - 1.33 - outperform

----------------- 

(from here)

 

Report this comment
#11) On September 02, 2009 at 2:28 PM, portefeuille (99.60) wrote:

This is the number of "groupies" of my players from portefeuille to portefeuille12 (at the last time I checked).

352 73 26 15 39 40 9 14 24 4 5 2.

update

387 78 33 24 43 49 14 20 30 10 11 6.

 

Report this comment
#12) On September 04, 2009 at 10:57 AM, mikecart1 (99.04) wrote:

Hey port man, September is here and everything is still intact. Where is the end of the world you speak of? lol.

j/k but yeah I'm up big in the stock market :D

Report this comment
#13) On September 04, 2009 at 4:51 PM, portefeuille (99.60) wrote:

j/k but yeah I'm up big in the stock market :D

I guess you must be joking. People here usually call me a stock market "bull".

Report this comment

Featured Broker Partners


Advertisement